JND3229   Click here for help

GtoPdb Ligand ID: 12986

Synonyms: JND-3229
Compound class: Synthetic organic
Comment: JND3229 is a fourth generation EGFR inhibitor [1]. It was designed to overcome osimertinib resistance due to the EGFRC797S mutation.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 10
Hydrogen bond donors 2
Rotatable bonds 8
Topological polar surface area 95.88
Molecular weight 617.19
XLogP 1.85
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCC(=O)NC1CCC(CC1)N2C3=C(C=NC(=N3)NC4=CC=C(C(=C4)C)N5CCN(C)CC5)CN(C6=C(C=CC=C6)Cl)C2=O
Isomeric SMILES CCC(=O)NC1CCC(CC1)N2C3=NC(=NC=C3CN(C2=O)C4=CC=CC=C4Cl)NC5=CC(=C(C=C5)N6CCN(CC6)C)C
InChI InChI=1S/C33H41ClN8O2/c1-4-30(43)36-24-9-12-26(13-10-24)42-31-23(21-41(33(42)44)29-8-6-5-7-27(29)34)20-35-32(38-31)37-25-11-14-28(22(2)19-25)40-17-15-39(3)16-18-40/h5-8,11,14,19-20,24,26H,4,9-10,12-13,15-18,21H2,1-3H3,(H,36,43)(H,35,37,38)
InChI Key WVLWGBZNXIVAKC-UHFFFAOYSA-N
References
1. Lu X, Zhang T, Zhu SJ, Xun Q, Tong L, Hu X, Li Y, Chan S, Su Y, Sun Y et al.. (2018)
Discovery of JND3229 as a New EGFRC797S Mutant Inhibitor with In Vivo Monodrug Efficacy.
ACS Med Chem Lett, 9 (11): 1123-1127. [PMID:30429956]